Merck KGaA (MRK) PT Set at €97.00 by Societe Generale
Merck KGaA (FRA:MRK) received a €97.00 ($107.78) price objective from Societe Generale in a report released on Monday. The firm presently has a a “neutral” rating on the stock.
MRK has been the subject of a number of other reports. BNP Paribas set a €114.00 ($126.67) price objective on Merck KGaA and gave the stock a “buy” rating in a report on Friday, September 30th. Citigroup Inc. set a €115.00 ($127.78) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Thursday, September 29th. Commerzbank AG set a €101.00 ($112.22) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Tuesday, August 30th. Bank of America Corp. set a €115.00 ($127.78) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Thursday, September 8th. Finally, Bankhaus Lampe set a €112.00 ($124.44) target price on Merck KGaA and gave the stock a “buy” rating in a research note on Tuesday, August 2nd. One analyst has rated the stock with a sell rating, twelve have given a hold rating and ten have assigned a buy rating to the company. Merck KGaA presently has a consensus rating of “Hold” and a consensus price target of €101.19 ($112.43).
Merck KGaA (FRA:MRK) opened at 97.054 on Monday. The firm’s 50-day moving average price is €95.75 and its 200-day moving average price is €89.96. Merck KGaA has a 1-year low of €70.87 and a 1-year high of €100.00. The company has a market cap of €42.20 billion and a price-to-earnings ratio of 30.367.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at http://www.americanbankingnews.com/2016/10/17/merck-kgaa-mrk-pt-set-at-97-00-by-societe-generale.html
About Merck KGaA
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.